Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

26 May 2017 07:00

RNS Number : 2927G
Plant Health Care PLC
26 May 2017
ย 

26 May 2017

Plant Health Care plc

("Plant Health Care" or the "Company")

Director / PDMR Shareholdings

Plant Health Care (AIM: PHC) was notified that on 23 May 2017, Richard Webb, Executive Director of the Company, purchased a total of 106,530 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at a price of 30 pence per Ordinary Share. Following the purchase, Richard Webb is beneficially interested in 868,400 Ordinary Shares, representing approximately 0.59 per cent. of the Company's issued share capital.

PHC was further notified that on 23 May 2017, Joelle Jenny, the spouse of Richard Webb purchased a total of 80,825 Ordinary Shares at a price of 30 pence per Ordinary Share. Following the purchase, Joelle Jenny, is beneficially interested in 80,825 Ordinary Shares, representing approximately 0.05 per cent. of the Company's issued share capital

ย 

Plant Health Care plc

Chris Richards - Executive Chairman and Interim CEO

Jeffrey Hovey - Chief Financial Officer

ย 

ย 

+1 919 926 1600

Liberum - Nomad and Broker

Clayton Bush

Chris Clarke

ย 

+44 (0) 203 100 2000

ย 

Company website: www.planthealthcare.com

ย 

1.

Details of the person discharging managerial responsibilities / person closely associated

ย 

a)

Name

Dr. Richard H Webb

Joelle Jenny

2.

Reason for the Notification

a)

Position/status

Executive Director

Spouse of Executive Director, Richard Webb

b)

Initial notification/ Amendment

Initial notification

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

Plant Health Care plc

b)

LEI

pending

pending

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares ofย 1 penny each

Ordinary Shares ofย 1 penny each

Identification code

GB00B01JC540

GB00B01JC540

b)

Nature of the transaction

Purchase of Ordinary shares

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price

Volume

Price

Volume

ยฃ0.30

106,530

ยฃ0.30

80,825

d)

Aggregated information:

ยทAggregated volume

ยทPrice

Single transaction as in 4c) above

106,530

ยฃ0.30

Single transaction as in 4c) above

80,825

ยฃ0.30

e)

Date of the transaction

23 May 2017

23 May 2017

f)

Place of the transaction

XLON

XLON

ย 

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
DSHSEIFMIFWSEDI
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.